The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sequence decision making for cabazitaxel (Cbz) versus abiraterone (Abt) or enzalutamide (Enz) post-docetaxel (Dtx) in a publicly funded health care system.
 
Alexander Watson
No Relationships to Disclose
 
Richard Gagnon
No Relationships to Disclose
 
Eugene Batuyong
Stock and Other Ownership Interests - Acasti Pharma; Actinium Pharmaceuticals; Adamis; Agenus; Amarin Corporation; Avadel Pharmaceuticals; Bausch Health; Bellicum Pharmaceuticals; Cassava Sciences; Catalyst Biosciences; Catalyst Biosciences; Cellectar; DelMar Pharmaceuticals; Durect Corporation; Epizyme; Genmab; Geron; Health Insurance Innovations; iBio; MEI Pharma; Onconova Therapeutics; Spectrum Pharmaceuticals; Trovagene; Vaxart; VBI Vaccines
 
Nimira S. Alimohamed
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Janssen; Merck; Pfizer; Sanofi
 
Richard M. Lee-Ying
Honoraria - Janssen
Consulting or Advisory Role - Amgen; Bayer; Celgene; Ipsen; Janssen; Pfizer; Sanofi
Speakers' Bureau - Amgen; Celgene; Janssen
Research Funding - Sanofi